Eustralis Pharmaceuticals Limited (trading as Pressura Neuro)
发明人:
Robert Vink
申请号：
US15817447
公开号：
US20180296564A1
申请日:
2017.11.20
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to a method for the prevention and/or treatment of chronic traumatic encephalopathy comprising administration of an effective amount of aprepitant (otherwise known as emend, fosaprepitant, ivemend, L754030, and ONO-7436). The invention further relates to the inhibition of progression of a disease, condition or state associated with tau hyperphosphorylation, and the treatment of a subject with a concussive injury.
